Literature DB >> 22344462

Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells.

Andrew Hsu1, Wenliang Zhang, Jen-Fu Lee, Jin An, Prasanna Ekambaram, Jingjing Liu, Kenneth V Honn, Carolyn M Klinge, Menq-Jer Lee.   

Abstract

Sphingosine-1-phosphate (S1P) regulates a wide array of biological functions. However, the role of S1P signaling in tumorigenesis remains to be elucidated. In this study, we show that S1P receptor subtype 3 (S1P₃) is markedly up-regulated in a subset of lung adenocarcinoma cells compared to normal lung epithelial cells. Specific knockdown of S1P₃ receptors inhibits proliferation and anchorage-independent growth of lung adenocarcinoma cells. Mechanistically, we demonstrate that S1P₃ signaling increases epidermal growth factor receptor (EGFR) expression via the Rho kinase (ROCK) pathway in lung adenocarcinoma cells. Nuclear run-off analysis indicates that S1P/S1P₃ signaling transcriptionally increases EGFR expression. Knockdown of S1P₃ receptors diminishes the S1P-stimulated EGFR expression in lung adenocarcinoma cells. Moreover, S1P treatment greatly enhances EGF-stimulated colony formation, proliferation and invasion of lung adenocarcinoma cells. Together, these results suggest that the enhanced S1P₃-EGFR signaling axis may contribute to the tumorigenesis or progression of lung adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22344462      PMCID: PMC3797598          DOI: 10.3892/ijo.2012.1379

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  40 in total

1.  Characterization of a novel sphingosine 1-phosphate receptor, Edg-8.

Authors:  D S Im; C E Heise; N Ancellin; B F O'Dowd; G J Shei; R P Heavens; M R Rigby; T Hla; S Mandala; G McAllister; S R George; K R Lynch
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

2.  A role of sphingosine kinase 1 in head and neck carcinogenesis.

Authors:  Keisuke Shirai; Tatsuya Kaneshiro; Masayuki Wada; Hideki Furuya; Jacek Bielawski; Yusuf A Hannun; Lina M Obeid; Besim Ogretmen; Toshihiko Kawamori
Journal:  Cancer Prev Res (Phila)       Date:  2011-01-05

Review 3.  Bioactive lysophospholipids and their G protein-coupled receptors.

Authors:  W H Moolenaar
Journal:  Exp Cell Res       Date:  1999-11-25       Impact factor: 3.905

4.  Sphingosine kinase 1/S1P pathway involvement in the GDNF-induced GAP43 transcription.

Authors:  Masashi Murakami; Hiromi Ito; Kazumi Hagiwara; Misa Kobayashi; Asuka Hoshikawa; Akira Takagi; Tetsuhito Kojima; Keiko Tamiya-Koizumi; Sayaka Sobue; Masatoshi Ichihara; Motoshi Suzuki; Yoshiko Banno; Yoshinori Nozawa; Takashi Murate
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

5.  Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate.

Authors:  M J Lee; S Thangada; K P Claffey; N Ancellin; C H Liu; M Kluk; M Volpi; R I Sha'afi; T Hla
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

6.  High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients.

Authors:  Carol Watson; Jaclyn S Long; Clare Orange; Claire L Tannahill; Elizabeth Mallon; Liane M McGlynn; Susan Pyne; Nigel J Pyne; Joanne Edwards
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

Review 7.  Sphingosine 1-phosphate and cancer.

Authors:  Nigel J Pyne; Susan Pyne
Journal:  Nat Rev Cancer       Date:  2010-06-17       Impact factor: 60.716

8.  FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.

Authors:  Dmitri Pchejetski; Torsten Bohler; Leyre Brizuela; Lysann Sauer; Nicolas Doumerc; Muriel Golzio; Vishal Salunkhe; Justin Teissié; Bernard Malavaud; Jonathan Waxman; Olivier Cuvillier
Journal:  Cancer Res       Date:  2010-10-19       Impact factor: 12.701

9.  Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy.

Authors:  Guanglin Liu; Haiqing Zheng; Zhibing Zhang; Zhiqiang Wu; Huaping Xiong; Jun Li; Libing Song
Journal:  BMC Cancer       Date:  2010-09-16       Impact factor: 4.430

10.  STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors.

Authors:  Heehyoung Lee; Jiehui Deng; Maciej Kujawski; Chunmei Yang; Yong Liu; Andreas Herrmann; Marcin Kortylewski; David Horne; George Somlo; Stephen Forman; Richard Jove; Hua Yu
Journal:  Nat Med       Date:  2010-11-21       Impact factor: 53.440

View more
  23 in total

Review 1.  An update on the biology of sphingosine 1-phosphate receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  J Lipid Res       Date:  2014-01-23       Impact factor: 5.922

2.  TGF-β/SMAD3 Pathway Stimulates Sphingosine-1 Phosphate Receptor 3 Expression: IMPLICATION OF SPHINGOSINE-1 PHOSPHATE RECEPTOR 3 IN LUNG ADENOCARCINOMA PROGRESSION.

Authors:  Jiawei Zhao; Jingjing Liu; Jen-Fu Lee; Wenliang Zhang; Mustapha Kandouz; Garrett C VanHecke; Shiyou Chen; Young-Hoon Ahn; Fulvio Lonardo; Menq-Jer Lee
Journal:  J Biol Chem       Date:  2016-11-17       Impact factor: 5.157

Review 3.  Sphingosine-1-phosphate receptor subtype 2 signaling in endothelial senescence-associated functional impairments and inflammation.

Authors:  Jiawei Zhao; Dante Garcia; Allison Gartung; Menq-Jer Lee
Journal:  Curr Atheroscler Rep       Date:  2015-05       Impact factor: 5.113

Review 4.  Targeting sphingosine-1-phosphate signaling in lung diseases.

Authors:  David L Ebenezer; Panfeng Fu; Viswanathan Natarajan
Journal:  Pharmacol Ther       Date:  2016-09-13       Impact factor: 12.310

5.  Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapy.

Authors:  Gabriela Schneider; Ewa Bryndza; Ahmed Abdel-Latif; Janina Ratajczak; Magdalena Maj; Maciej Tarnowski; Yuri M Klyachkin; Peter Houghton; Andrew J Morris; Axel Vater; Sven Klussmann; Magdalena Kucia; Mariusz Z Ratajczak
Journal:  Mol Cancer Res       Date:  2013-04-24       Impact factor: 5.852

6.  Sphingosine-1-phosphate receptor-2 mediated NFκB activation contributes to tumor necrosis factor-α induced VCAM-1 and ICAM-1 expression in endothelial cells.

Authors:  Wenliang Zhang; Jin An; Hiba Jawadi; Deanna L Siow; Jen-Fu Lee; Jiawei Zhao; Allison Gartung; Krishna Rao Maddipati; Kenneth V Honn; Binks W Wattenberg; Menq-Jer Lee
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-06-11       Impact factor: 3.072

Review 7.  Sphingosine-1-phosphate receptor 2.

Authors:  Mohamad Adada; Daniel Canals; Yusuf A Hannun; Lina M Obeid
Journal:  FEBS J       Date:  2013-08-19       Impact factor: 5.542

Review 8.  A review of ceramide analogs as potential anticancer agents.

Authors:  Jiawang Liu; Barbara S Beckman; Maryam Foroozesh
Journal:  Future Med Chem       Date:  2013-08       Impact factor: 3.808

9.  ETS-1-mediated transcriptional up-regulation of CD44 is required for sphingosine-1-phosphate receptor subtype 3-stimulated chemotaxis.

Authors:  Wenliang Zhang; Jiawei Zhao; Jen-Fu Lee; Allison Gartung; Hiba Jawadi; Wanyu Louis Lambiv; Kenneth V Honn; Menq-Jer Lee
Journal:  J Biol Chem       Date:  2013-09-24       Impact factor: 5.157

Review 10.  Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.

Authors:  M T M van Jaarsveld; J M Houthuijzen; E E Voest
Journal:  Oncogene       Date:  2015-12-07       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.